Hereditary Transthyretin Amyloidosis (hATTR)- Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2030

  • RnM4192357
  • |
  • 07 September, 2020
  • |
  • 200 Pages
  • |
  • DelveInsight
  • |
  • Pharma & Healthcare

Check Discount on this report



Purchase this Report

$6,950.00
$13,900.00
$20,850.00
5,560.00
11,120.00
16,680.00
6,491.30
12,982.60
19,473.90
1,097,683.00
2,195,366.00
3,293,049.00
579,838.50
1,159,677.00
1,739,515.50
Credit card Logo